Keith Lamont Cummings - 02 May 2024 Form 4 Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Signature
/s/ Mike Ouimette, attorney-in-fact
Issuer symbol
PLRX
Transactions as of
02 May 2024
Net transactions value
+$43,680
Form type
4
Filing time
06 May 2024, 06:02:45 UTC
Previous filing
24 Jan 2024
Next filing
11 Jul 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLRX Common Stock Options Exercise $43,680 +21,000 +8.4% $2.08 271,713 02 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLRX Stock Option (Right to Buy) Options Exercise $0 -21,000 -22% $0.000000 76,047 02 May 2024 Common Stock 21,000 $2.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 858 shares of Common Stock acquired by the Reporting Person pursuant to an Employee Stock Purchase Plan program.
F2 25% of the shares subject to such option vested on December 31, 2019 and 1/48th of the shares subject to the option vested in substantially equal monthly installments thereafter, all of which were subject to the Reporting Person's continuous service to the Issuer on each such date.